TrialNeurology2018
Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study.
Bernice Kuca et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
109 papers cite itlatest 60 shown
this paperpooled ittrialcites it